Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA

This study is ongoing, but not recruiting participants.

First Received on September 21, 2007. Last Updated on December 11, 2011 History of Changes

Sponsor:	King Faisal Specialist Hospital & Research Center
Information provided by (Responsible Party):	King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:	NCT00534729

Purpose

Organ Preservation: Weekly Carboplatin & Taxol w/concurrent RT for locally advanced laryngeal & Hypopharyngeal CA

Condition	Intervention
Laryngeal Neoplasms Hypopharyngeal Neoplasms	Drug: Weekly Carboplatin & Taxol w/concurrent RT

Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Cancer

Drug Information available for: Paclitaxel Carboplatin

U.S. FDA Resources

Further study details as provided by King Faisal Specialist Hospital & Research Center:

Primary Outcome Measures:

safety [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Estimated Enrollment:	200
Study Start Date:	September 2007
Estimated Study Completion Date:	September 2015
Estimated Primary Completion Date:	September 2015 (Final data collection date for primary outcome measure)

Intervention Details:

Chemotherapy

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with locally advanced laryngeal & Hypopharyngeal CA

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00534729

Locations

Saudi Arabia
KFSH&RC
Riyadh, Saudi Arabia, 1211

Sponsors and Collaborators

King Faisal Specialist Hospital & Research Center

Investigators

Principal Investigator:

Nasser Al-Rajhi, MD

KFSH&RC

More Information

No publications provided

Responsible Party:	King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:	NCT00534729 History of Changes
Other Study ID Numbers:	RAC#0971-024
Study First Received:	September 21, 2007
Last Updated:	December 11, 2011
Health Authority:	United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:

Organ Preservation
Carboplatin
Taxol

RT
laryngeal & Hypopharyngeal CA
Locally advanced laryngeal & Hypopharyngeal CA

Additional relevant MeSH terms:

Neoplasms
Hypopharyngeal Neoplasms
Laryngeal Neoplasms
Pharyngeal Neoplasms
Otorhinolaryngologic Neoplasms
Head and Neck Neoplasms
Neoplasms by Site
Pharyngeal Diseases
Stomatognathic Diseases
Otorhinolaryngologic Diseases
Laryngeal Diseases
Respiratory Tract Diseases

Respiratory Tract Neoplasms
Carboplatin
Paclitaxel
Antineoplastic Agents
Therapeutic Uses
Pharmacologic Actions
Tubulin Modulators
Antimitotic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents, Phytogenic

ClinicalTrials.gov processed this record on February 09, 2012